{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:29:30Z","timestamp":1781706570741,"version":"3.54.5"},"reference-count":28,"publisher":"Cambridge University Press (CUP)","issue":"12","license":[{"start":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:00:00Z","timestamp":1528675200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["www.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fever is a common adverse event following measles vaccination, more frequent among older children and those receiving Measles-Mumps-Rubella-Varicella vaccine<jats:italic>vs.<\/jats:italic>Measles-Mumps-Rubella vaccine, two factors associated with a better antibody response. However, the role of fever in the immunogenicity of measles-containing vaccines (MCV) is unclear. We performed a post-hoc pooled analysis of data of 5 216 11 to 22 month-old children receiving MCV from 2004 to 2012 in Europe and USA to evaluate the association between post-immunisation fever and antibody response, measured by geometric mean concentrations (GMCs). We further evaluated fever as an effect modifier or a mediator in the associations between the type of MCV or the age at first vaccination and vaccine immunogenicity. After the first dose, fever was associated with 60% higher GMCs (95% CI 1.51\u20131.68). For children vaccinated at \u2a7e12 months, the fever did not modify and minimally mediated (2% to 3%) the association between age and antibody response. Fever mediated 18% of the association between type of MCV and GMCs. In a model including fever, age and type of vaccine, fever was the strongest predictor of GMCs. These results suggest that fever is associated with a stronger measles antibody response independently of age and type of MCV.<\/jats:p>","DOI":"10.1017\/s0950268818001474","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T07:37:51Z","timestamp":1528702671000},"page":"1584-1592","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":8,"title":["Post-immunisation fever and the antibody response to measles-containing vaccines"],"prefix":"10.1017","volume":"146","author":[{"given":"S.","family":"Carazo Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1592-5167","authenticated-orcid":false,"given":"G.","family":"De Serres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2018,6,11]]},"reference":[{"key":"S0950268818001474_ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nri3843"},{"key":"S0950268818001474_ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5438.817"},{"key":"S0950268818001474_ref17","doi-asserted-by":"publisher","DOI":"10.2741\/1341"},{"key":"S0950268818001474_ref24","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001241"},{"key":"S0950268818001474_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91044-5"},{"key":"S0950268818001474_ref3","volume-title":"Medical Microbiology","author":"Enders","year":"1996"},{"key":"S0950268818001474_ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2013.2745"},{"key":"S0950268818001474_ref14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix510"},{"key":"S0950268818001474_ref12","doi-asserted-by":"publisher","DOI":"10.3390\/v8100282"},{"key":"S0950268818001474_ref1","first-page":"62","volume-title":"The Immunological Basis for Immunization Series","author":"Moss","year":"2009"},{"key":"S0950268818001474_ref10","doi-asserted-by":"publisher","DOI":"10.4161\/hv.2.5.3246"},{"key":"S0950268818001474_ref22","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/clinids\/5.3.596","article-title":"Seroconversion rates and measles antibody-titers induced by measles vaccination in Latin-American children 6 to 12 months of age","volume":"5","author":"Dequadros","year":"1983","journal-title":"Reviews of Infectious Diseases"},{"key":"S0950268818001474_ref15","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e318281a64e"},{"key":"S0950268818001474_ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001721"},{"key":"S0950268818001474_ref13","doi-asserted-by":"publisher","DOI":"10.1037\/a0031034"},{"key":"S0950268818001474_ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196007282630405"},{"key":"S0950268818001474_ref28","doi-asserted-by":"publisher","DOI":"10.2741\/2767"},{"key":"S0950268818001474_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62352-5"},{"key":"S0950268818001474_ref20","volume-title":"Medical Microbiology","author":"Dianzani","year":"1996"},{"key":"S0950268818001474_ref19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2249.2005.02931.x","article-title":"Correlations among measles virus-specific antibody, lymphoproliferation and Th1\/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination","volume":"142","author":"Dhiman","year":"2005","journal-title":"Clinical and Experimental Immunology"},{"key":"S0950268818001474_ref11","doi-asserted-by":"publisher","DOI":"10.1007\/BF01957751"},{"key":"S0950268818001474_ref16","doi-asserted-by":"publisher","DOI":"10.1586\/erv.12.134"},{"key":"S0950268818001474_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00207-9"},{"key":"S0950268818001474_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00096-7"},{"key":"S0950268818001474_ref25","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318259fc8a"},{"key":"S0950268818001474_ref6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-3429"},{"key":"S0950268818001474_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.02.062"},{"key":"S0950268818001474_ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1971.03190140033006"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268818001474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T11:44:00Z","timestamp":1661427840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268818001474\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,11]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0950268818001474"],"URL":"https:\/\/doi.org\/10.1017\/s0950268818001474","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,11]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2018\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}